Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

modernretina.com image

News from modernretina.com

See all of modernretina.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

In total, 150 have been published by modernretina.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for modernretina.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

modernretina.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about modernretina.com

Where is modernretina.com located?modernretina.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top modernretina.com News

Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies

Artificial Intelligence · Aurora

Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies

74% Center coverage: 8 sources

The anonymous gift to Colorado's only academic eye center will boost research into treating and curing the most serious eye diseases while investing in new technology and recruiting top talent See the Story

Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

South Korea · South Korea

Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

100% Right coverage: 1 sources

**media[646566]**See the Story

Ranibizumab Ocular Implant Shows Long-Term Benefits in Retinal Disease

Ranibizumab Ocular Implant Shows Long-Term Benefits in Retinal Disease

100% Center coverage: 1 sources

(MedPage Today) -- The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and structural updates to the device...See the Story

EyeCare Partners releases Quality and Outcomes Report, highlights optometric successes

The report highlights clinical successes, innovation, research, and patient outcomes.Innovation See the Story

Early diabetic retinopathy detection may be found in biomarker changes

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.Read Article

ZEISS fundus imaging device receives NMPA approval in China

CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.China · China See the Story

AMD, AI, and the future of eye imaging: Inside the 2025 International SPECTRALIS Symposium

With 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and sceneryArtificial Intelligence · Heidelberg See the Story

NIH Study Identifies Brain Circuits Critical to Visual Acuity Beyond the Retina

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.Bethesda, Maryland · Bethesda See the Story

Silicon-free plunger for ophthalmic drug delivery

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.Read Article

ViGeneron Rebrands as VeonGen Therapeutics, Announces Rare Pediatric Disease Designation for VG801

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.See the Story

ZEISS CLARUS 700 Secures Approval in China

Next-gen eye imaging system brings advanced diagnostics to Chinese clinics.Tokyo, Japan · Tokyo See the Story

Breaking News Topics Related to modernretina.com